Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03353792 · ClinicalTrials.gov registry record · NA

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients

A NA study, sponsored by Yale University.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT03353792 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03353792, a NA study, was terminated before completion, sponsored by Yale University.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

To demonstrate that a new insulin pump system can prevent low glucose episodes and improve brain function in aged Type 1 diabetes mellitus subjects.

Interventions

  • DEVICE CL/AP system
  • DEVICE usual diabetic care

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2017-11-01
Est. Completion 2019-08-28
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT03353792

The ClinicalTrials.gov registry entry for NCT03353792 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which CL/AP system is the first listed.

NCT03353792 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03353792 about?

NCT03353792 is a clinical study titled "Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients". To demonstrate that a new insulin pump system can prevent low glucose episodes and improve brain function in aged Type 1 diabetes mellitus subjects.

What is the current status of trial NCT03353792?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-11-01. Estimated completion is 2019-08-28.

What interventions are being tested in trial NCT03353792?

The interventions under investigation include: CL/AP system (DEVICE), usual diabetic care (DEVICE).

Who is sponsoring clinical trial NCT03353792?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.